Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALEMTUZUMAB Cause Dyspnoea? 855 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 855 reports of Dyspnoea have been filed in association with ALEMTUZUMAB (Campath). This represents 6.0% of all adverse event reports for ALEMTUZUMAB.

855
Reports of Dyspnoea with ALEMTUZUMAB
6.0%
of all ALEMTUZUMAB reports
44
Deaths
425
Hospitalizations

How Dangerous Is Dyspnoea From ALEMTUZUMAB?

Of the 855 reports, 44 (5.1%) resulted in death, 425 (49.7%) required hospitalization, and 63 (7.4%) were considered life-threatening.

Is Dyspnoea Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 855 reports have been filed with the FAERS database.

What Other Side Effects Does ALEMTUZUMAB Cause?

Headache (1,808) Fatigue (1,744) Pyrexia (1,441) Off label use (1,259) Rash (1,094) Nausea (1,053) Lymphocyte count decreased (852) Asthenia (841) Multiple sclerosis relapse (836) Urinary tract infection (746)

What Other Drugs Cause Dyspnoea?

ALBUTEROL (21,856) TREPROSTINIL (16,348) AMBRISENTAN (13,367) PREDNISONE (12,830) BUDESONIDE\FORMOTEROL (11,158) TIOTROPIUM (10,863) ADALIMUMAB (10,547) DUPILUMAB (10,310) FLUTICASONE\SALMETEROL (9,783) MEPOLIZUMAB (9,192)

Which ALEMTUZUMAB Alternatives Have Lower Dyspnoea Risk?

ALEMTUZUMAB vs ALENDRONATE ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL ALEMTUZUMAB vs ALENDRONIC ACID ALEMTUZUMAB vs ALEVE ALEMTUZUMAB vs ALEVE CAPLET

Related Pages

ALEMTUZUMAB Full Profile All Dyspnoea Reports All Drugs Causing Dyspnoea ALEMTUZUMAB Demographics